As an internationally established company in the pharmaceutical and health care markets, the Otsuka Group benefits from the synergy created in a multicultural environment. Worldwide, more than 158 companies with a total of 42,150 employees work for the development, commercialization, and marketing of new medicines and products that promote better health.
Otsuka has worked hard to earn its place as one of the five largest pharmaceutical companies in Japan. The Japanese word "Otsuka" means "major milestone,” which is apt since the company has hit and surpassed many milestones since its foundation in 1921.
Otsuka Novel Products GmbH
Otsuka Novel Products GmbH (ONPG) is part of the global Otsuka Group (Otsuka).
Otsuka Novel Products GmbH was founded in 2011 in Munich, Germany, to distribute novel pharmaceutical products as well as to focus on clinical development, which includes conducting clinical phase I, phase II, and phase III trials as well as post-authorization safety studies (PASS).
As the designated holder of marketing authorizations in Europe, ONPG is responsible for all necessary functions including supply chain management, medical affairs & medical information, pharmacovigilance reporting, market access, market development & communication, and business development.